Skip to content
10-Q

Quarterly Report

MEDRESPONSE CORP.

0001477932-17-004711

← back to feed
Filed
Sep 25, 2017 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2017 · Sep 25, 2017 9.56M sh
Operating Cash Flow Q2 2017 · Jun 30, 2017 −$5.19K
Operating Cash Flow Q2 2017 · Jun 30, 2016 −$168
Cash And Equivalents Q2 2017 · Jun 30, 2017 $778
Cash And Equivalents Q2 2017 · Dec 31, 2016 $862
Cash And Equivalents Q2 2017 · Jun 30, 2016 $932
Cash And Equivalents Q2 2017 · Dec 31, 2015 $100
Stockholders Equity Q2 2017 · Jun 30, 2017 −$31.29K
Stockholders Equity Q2 2017 · Dec 31, 2016 −$27.6K
Current Liabilities Q2 2017 · Jun 30, 2017 $32.07K
Current Liabilities Q2 2017 · Dec 31, 2016 $28.47K
Total Liabilities Q2 2017 · Jun 30, 2017 $32.07K
Total Liabilities Q2 2017 · Dec 31, 2016 $28.47K
Current Assets Q2 2017 · Jun 30, 2017 $778
Current Assets Q2 2017 · Dec 31, 2016 $862
Total Assets Q2 2017 · Jun 30, 2017 $778
Total Assets Q2 2017 · Dec 31, 2016 $862
Net Income Q2 2017 · Jun 30, 2017 −$342
Net Income Q2 2017 · Jun 30, 2017 −$3.68K
Net Income Q2 2017 · Jun 30, 2016 −$1.72K
Net Income Q2 2017 · Jun 30, 2016 −$9.03K
Operating Income Q2 2017 · Jun 30, 2017 −$342
Operating Income Q2 2017 · Jun 30, 2017 −$3.68K
Operating Income Q2 2017 · Jun 30, 2016 −$1.38K
Operating Income Q2 2017 · Jun 30, 2016 −$8.35K